Member Login

              Click here if you forgot your password.

Current Events

Webinar: The new Annex 21

Tuesday, 21 April 2020
14.30 - 16.00 h

Webinar: The new EMA Reflection Paper on GMP and Marketing Authorisation Holders

Thursday, 23 April 2020
14.00 - 15.30 h

EQPA Members Area

IMP Working Group Members Area

Document and track your personal development - with the Continuous Professional Development (CPD) Documentation Template

To access the template for documenting and tracking your past and ongoing activities, please go here.

After filling out the form, you will be able to create and print out a PDF file.

Hard Brexit: MHRA Preparations


Boris Johnson's election as Prime Minister has made it very likely that the UK will leave the EU on 31 October this year. And the likelihood of a withdrawal without an agreement ("Hard Brexit ") can no longer be dismissed. Pharmaceutical authorities see challenges for pharmaceutical manufacturers in many areas, not only in terms of drug availability or drug testing.

The MHRA has already published several guidelines for a possible no-deal scenario. This concerns the following areas:

A comprehensive overview can be found in the Collection "MHRA guidance and publications about a possible no-deal Brexit".


Conference Recommendations